{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:52:27Z","timestamp":1789167147227,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,9,20]],"date-time":"2009-09-20T00:00:00Z","timestamp":1253404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s11894-009-0053-z","type":"journal-article","created":{"date-parts":[[2009,9,19]],"date-time":"2009-09-19T21:16:48Z","timestamp":1253395008000},"page":"345-353","source":"Crossref","is-referenced-by-count":15,"title":["NSAIDs and the gastrointestinal tract"],"prefix":"10.1007","volume":"11","author":[{"given":"Maneesh","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,20]]},"reference":[{"key":"53_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2036.2008.03706.x","volume":"28","author":"N.S. Abraham","year":"2008","unstructured":"Abraham NS, Castillo DL, Hartman C: National mortality following upper gastrointestinal or cardiovascular events in older veterans with recent nonsteroidal anti-inflammatory drug use. Aliment Pharmacol Ther 2008, 28:97\u2013106.","journal-title":"Aliment Pharmacol Ther"},{"key":"53_CR2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1053\/bega.2001.0232","volume":"15","author":"M. Bidaut-Russell","year":"2001","unstructured":"Bidaut-Russell M, Gabriel SE: Adverse gastrointestinal effects of NSAIDs: consequences and costs. Best Pract Res Clin Gastroenterol 2001, 15:739\u2013753.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"53_CR3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0016-5085(89)80058-7","volume":"96","author":"R. Pounder","year":"1989","unstructured":"Pounder R: Silent peptic ulceration: deadly silence or golden silence? Gastroenterology 1989, 96:626\u2013631.","journal-title":"Gastroenterology"},{"key":"53_CR4","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.2001.21907","volume":"120","author":"L. Laine","year":"2001","unstructured":"Laine L: Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 2001, 120:594\u2013606.","journal-title":"Gastroenterology"},{"key":"53_CR5","first-page":"18","volume":"56","author":"G. Singh","year":"1999","unstructured":"Singh G, Triadafilopoulos G: Epidemiology of NSAIDinduced gastrointestinal complications. J Rheumatol Suppl 1999, 56:18\u201324.","journal-title":"J Rheumatol Suppl"},{"key":"53_CR6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","volume":"284","author":"F.E. Silverstein","year":"2000","unstructured":"Silverstein FE, Faich G, Goldstein JL, et al.: Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000, 284:1247\u20131255.","journal-title":"JAMA"},{"key":"53_CR7","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","volume":"343","author":"C. Bombardier","year":"2000","unstructured":"Bombardier C, Laine L, Reicin A, et al.: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000, 343:1520\u20131528.","journal-title":"N Engl J Med"},{"key":"53_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","volume":"123","author":"F.E. Silverstein","year":"1995","unstructured":"Silverstein FE, Graham DY, Senior JR, et al.: Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995, 123:241\u2013249.","journal-title":"Ann Intern Med"},{"key":"53_CR9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","volume":"115","author":"S.E. Gabriel","year":"1991","unstructured":"Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991, 115:787\u2013796.","journal-title":"Ann Intern Med"},{"key":"53_CR10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-114-4-257","volume":"114","author":"M.R. Griffin","year":"1991","unstructured":"Griffin MR, Piper JM, Daugherty JR, et al.: Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991, 114:257\u2013263.","journal-title":"Ann Intern Med"},{"key":"53_CR11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-114-9-735","volume":"114","author":"J.M. Piper","year":"1991","unstructured":"Piper JM, Ray WA, Daugherty JR, Griffin MR: Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991, 114:735\u2013740.","journal-title":"Ann Intern Med"},{"key":"53_CR12","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archinte.1993.00410140047006","volume":"153","author":"R.I. Shorr","year":"1993","unstructured":"Shorr RI, Ray WA, Daugherty JR, Griffin MR: Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993, 153:1665\u20131670.","journal-title":"Arch Intern Med"},{"key":"53_CR13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ajg.2009.115","volume":"104","author":"F.L. Lanza","year":"2009","unstructured":"Lanza FL, Chan FK, Quigley EM: Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009, 104:728\u2013738.","journal-title":"Am J Gastroenterol"},{"key":"53_CR14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/ard.2003.015925","volume":"63","author":"F. Richy","year":"2004","unstructured":"Richy F, Bruyere O, Ethgen O, et al.: Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis 2004, 63:759\u2013766.","journal-title":"Ann Rheum Dis"},{"key":"53_CR15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","volume":"119","author":"K.R. McQuaid","year":"2006","unstructured":"McQuaid KR, Laine L: Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med 2006, 119:624\u2013638.","journal-title":"Am J Med"},{"key":"53_CR16","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1572-0241.2000.02248.x","volume":"95","author":"H.T. Sorensen","year":"2000","unstructured":"Sorensen HT, Mellemkjaer L, Blot WJ, et al.: Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000, 95:2218\u20132224.","journal-title":"Am J Gastroenterol"},{"key":"53_CR17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","volume":"359","author":"J.Q. Huang","year":"2002","unstructured":"Huang JQ, Sridhar S, Hunt RH: Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002, 359:14\u201322.","journal-title":"Lancet"},{"key":"53_CR18","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2005.02444.x","volume":"21","author":"M. Vergara","year":"2005","unstructured":"Vergara M, Catalan M, Gisbert JP, Calvet X: Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 2005, 21:1411\u20131418.","journal-title":"Aliment Pharmacol Ther"},{"key":"53_CR19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cgh.2005.10.006","volume":"4","author":"G.V. Papatheodoridis","year":"2006","unstructured":"Papatheodoridis GV, Sougioultzis S, Archimandritis AJ: Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol 2006, 4:130\u2013142.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"53_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(02)07272-0","volume":"359","author":"F.K. Chan","year":"2002","unstructured":"Chan FK, To KF, Wu JC, et al.: Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting longterm treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002, 359:9\u201313.","journal-title":"Lancet"},{"key":"53_CR21","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta11510","volume":"11","author":"G.I. Leontiadis","year":"2007","unstructured":"Leontiadis GI, Sreedharan A, Dorward S, et al.: Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess 2007, 11:iii\u2013iv, 1\u2013164.","journal-title":"Health Technol Assess"},{"key":"53_CR22","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/archinte.162.18.2105","volume":"162","author":"H.B. El-Serag","year":"2002","unstructured":"El-Serag HB, Graham DY, Richardson P, Inadomi JM: Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med 2002, 162:2105\u20132110.","journal-title":"Arch Intern Med"},{"key":"53_CR23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","volume":"344","author":"F.K. Chan","year":"2001","unstructured":"Chan FK, Chung SC, Suen BY, et al.: Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001, 344:967\u2013973.","journal-title":"N Engl J Med"},{"key":"53_CR24","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1001\/archinte.163.13.1606","volume":"163","author":"N.L. Arents","year":"2003","unstructured":"Arents NL, Thijs JC, van Zwet AA, et al.: Approach to treatment of dyspepsia in primary care: a randomized trial comparing \u201ctest-and-treat\u201d with prompt endoscopy. Arch Intern Med 2003, 163:1606\u20131612.","journal-title":"Arch Intern Med"},{"key":"53_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(00)02553-8","volume":"356","author":"A.T. Lassen","year":"2000","unstructured":"Lassen AT, Pedersen FM, Bytzer P, Schaffalitzky de Muckadell OB: Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000, 356:455\u2013460.","journal-title":"Lancet"},{"key":"53_CR26","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/bmj.326.7399.1118","volume":"326","author":"G. Manes","year":"2003","unstructured":"Manes G, Menchise A, de Nucci C, Balzano A: Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment. BMJ 2003, 326:1118.","journal-title":"BMJ"},{"key":"53_CR27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","volume":"338","author":"C.J. Hawkey","year":"1998","unstructured":"Hawkey CJ, Karrasch JA, Szczepanski L, et al.: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998, 338:727\u2013734.","journal-title":"N Engl J Med"},{"key":"53_CR28","first-page":"204","volume":"28","author":"L.S. Simon","year":"1996","unstructured":"Simon LS, Hatoum HT, Bittman RM, et al.: Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial. Family Medicine 1996, 28:204\u2013210.","journal-title":"Family Medicine"},{"key":"53_CR29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archinte.162.2.169","volume":"162","author":"D.Y. Graham","year":"2002","unstructured":"Graham DY, Agrawal NM, Campbell DR, et al.: Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med 2002, 162:169\u2013175.","journal-title":"Arch Intern Med"},{"key":"53_CR30","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","volume":"354","author":"P. Emery","year":"1999","unstructured":"Emery P, Zeidler H, Kvien TK, et al.: Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet 1999, 354:2106\u20132111.","journal-title":"Lancet"},{"key":"53_CR31","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.282.20.1921","volume":"282","author":"L.S. Simon","year":"1999","unstructured":"Simon LS, Weaver AL, Graham DY, et al.: Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA 1999, 282:1921\u20131928.","journal-title":"JAMA"},{"key":"53_CR32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(04)16893-1","volume":"364","author":"T.J. Schnitzer","year":"2004","unstructured":"Schnitzer TJ, Burmester GR, Mysler E, et al.: Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 2004, 364:665\u2013674.","journal-title":"Lancet"},{"key":"53_CR33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0140-6736(07)60234-7","volume":"369","author":"L. Laine","year":"2007","unstructured":"Laine L, Curtis SP, Cryer B, et al.: Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Longterm (MEDAL) programme: a randomised comparison. Lancet 2007, 369:465\u2013473.","journal-title":"Lancet"},{"key":"53_CR34","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cgh.2007.03.011","volume":"5","author":"A. Rostom","year":"2007","unstructured":"Rostom A, Muir K, Dube C, et al.: Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. Clin Gastroenterol Hepatol 2007, 5:818\u2013828, 828.e1-5; quiz 768.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"53_CR35","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa021907","volume":"347","author":"F.K. Chan","year":"2002","unstructured":"Chan FK, Hung LC, Suen BY, et al.: Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 2002, 347:2104\u20132110.","journal-title":"N Engl J Med"},{"key":"53_CR36","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(07)60749-1","volume":"369","author":"F.K. Chan","year":"2007","unstructured":"Chan FK, Wong VW, Suen BY, et al.: Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet 2007, 369:1621\u20131626.","journal-title":"Lancet"},{"key":"53_CR37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","volume":"338","author":"N.D. Yeomans","year":"1998","unstructured":"Yeomans ND, Tulassay Z, Juhasz L, et al.: A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998, 338:719\u2013726.","journal-title":"N Engl J Med"},{"key":"53_CR38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2036.2008.03780.x","volume":"28","author":"E.L. Masso Gonzalez","year":"2008","unstructured":"Masso Gonzalez EL, Garcia Rodriguez LA: Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study. Aliment Pharmacol Ther 2008, 28:629\u2013637.","journal-title":"Aliment Pharmacol Ther"},{"key":"53_CR39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/bmj.297.6655.1017","volume":"297","author":"R.S. Ehsanullah","year":"1988","unstructured":"Ehsanullah RS, Page MC, Tildesley G, Wood JR: Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ 1988, 297:1017\u20131021.","journal-title":"BMJ"},{"key":"53_CR40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF01536266","volume":"34","author":"M.G. Robinson","year":"1989","unstructured":"Robinson MG, Griffin JW Jr, Bowers J, et al.: Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 1989, 34:424\u2013428.","journal-title":"Dig Dis Sci"},{"key":"53_CR41","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM199605303342204","volume":"334","author":"A.S. Taha","year":"1996","unstructured":"Taha AS, Hudson N, Hawkey CJ, et al.: Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996, 334:1435\u20131439.","journal-title":"N Engl J Med"},{"key":"53_CR42","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(06)69666-9","volume":"368","author":"C.P. Cannon","year":"2006","unstructured":"Cannon CP, Curtis SP, FitzGerald GA, et al.: Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 2006, 368:1771\u20131781.","journal-title":"Lancet"},{"key":"53_CR43","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1572-0241.2008.01811.x","volume":"103","author":"E. Rahme","year":"2008","unstructured":"Rahme E, Barkun A, Nedjar H, et al.: Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol 2008, 103:872\u2013882.","journal-title":"Am J Gastroenterol"},{"key":"53_CR44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0016-5085(87)90909-7","volume":"93","author":"I. Bjarnason","year":"1987","unstructured":"Bjarnason I, Zanelli G, Smith T, et al.: Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987, 93:480\u2013489.","journal-title":"Gastroenterology"},{"key":"53_CR45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00535-008-2266-6","volume":"44Suppl19","author":"I. Bjarnason","year":"2009","unstructured":"Bjarnason I, Takeuchi K: Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J Gastroenterol 2009, 44(Suppl 19):23\u201329.","journal-title":"J Gastroenterol"},{"key":"53_CR46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/00365520701794121","volume":"43","author":"T. Matsumoto","year":"2008","unstructured":"Matsumoto T, Kudo T, Esaki M, et al.: Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol 2008, 43:490\u2013496.","journal-title":"Scand J Gastroenterol"},{"key":"53_CR47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1542-3565(04)00603-2","volume":"3","author":"D.Y. Graham","year":"2005","unstructured":"Graham DY, Opekun AR, Willingham FF, Qureshi WA: Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005, 3:55\u201359.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"53_CR48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1542-3565(04)00619-6","volume":"3","author":"J.L. Goldstein","year":"2005","unstructured":"Goldstein JL, Eisen GM, Lewis B, et al.: Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005, 3:133\u2013141.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"53_CR49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/gut.45.3.362","volume":"45","author":"J.A. Tibble","year":"1999","unstructured":"Tibble JA, Sigthorsson G, Foster R, et al.: High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999, 45:362\u2013366.","journal-title":"Gut"},{"key":"53_CR50","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/j.gastro.2005.03.020","volume":"128","author":"L. Maiden","year":"2005","unstructured":"Maiden L, Thjodleifsson B, Theodors A, et al.: A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005, 128:1172\u20131178.","journal-title":"Gastroenterology"},{"key":"53_CR51","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1365-2036.2007.03312.x","volume":"25","author":"J.L. Goldstein","year":"2007","unstructured":"Goldstein JL, Eisen GM, Lewis B, et al.: Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther 2007, 25:1211\u20131222.","journal-title":"Aliment Pharmacol Ther"},{"key":"53_CR52","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2008.12.019","volume":"7","author":"E. Smecuol","year":"2009","unstructured":"Smecuol E, Pinto Sanchez MI, Suarez A, et al.: Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol 2009, 7:524\u2013529.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"53_CR53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/01.meg.0000230080.59135.e1","volume":"18","author":"M. Montalto","year":"2006","unstructured":"Montalto M, Curigliano V, Santoro L, et al.: Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. Eur J Gastroenterol Hepatol 2006, 18:965\u2013967.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"53_CR54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1542-3565(03)70031-7","volume":"1","author":"R.W. Lengeling","year":"2003","unstructured":"Lengeling RW, Mitros FA, Brennan JA, Schulze KS: Ulcerative ileitis encountered at ileo-colonoscopy: likely role of nonsteroidal agents. Clin Gastroenterol Hepatol 2003, 1:160\u2013169.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"53_CR55","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/gut.33.7.887","volume":"33","author":"A.J. Morris","year":"1992","unstructured":"Morris AJ, Wasson LA, MacKenzie JF: Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992, 33:887\u2013889.","journal-title":"Gut"},{"key":"53_CR56","first-page":"250","volume":"185","author":"W.F. Kessler","year":"1997","unstructured":"Kessler WF, Shires GT 3rd, Fahey TJ 3rd: Surgical complications of nonsteroidal antiinflammatory drug-induced small bowel ulceration. J Am Coll Surg 1997, 185:250\u2013254.","journal-title":"J Am Coll Surg"},{"key":"53_CR57","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/bega.2001.0231","volume":"15","author":"S. Smale","year":"2001","unstructured":"Smale S, Tibble J, Sigthorsson G, Bjarnason I: Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Pract Res Clin Gastroenterol 2001, 15:723\u2013738.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"53_CR58","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/gut.40.5.619","volume":"40","author":"J.M. Evans","year":"1997","unstructured":"Evans JM, McMahon AD, Murray FE, et al.: Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 1997, 40:619\u2013622.","journal-title":"Gut"},{"key":"53_CR59","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","volume":"95","author":"J.B. Felder","year":"2000","unstructured":"Felder JB, Korelitz BI, Rajapakse R, et al.: Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol 2000, 95:1949\u20131954.","journal-title":"Am J Gastroenterol"},{"key":"53_CR60","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2036.2004.01907.x","volume":"19","author":"L. Biancone","year":"2004","unstructured":"Biancone L, Tosti C, Geremia A, et al.: Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial. Aliment Pharmacol Ther 2004, 19:755\u2013764.","journal-title":"Aliment Pharmacol Ther"},{"key":"53_CR61","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00054725-200407000-00005","volume":"10","author":"R. Matuk","year":"2004","unstructured":"Matuk R, Crawford J, Abreu MT, et al.: The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease. Inflamm Bowel Dis 2004, 10:352\u2013356.","journal-title":"Inflamm Bowel Dis"},{"key":"53_CR62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2005.12.002","volume":"4","author":"W.J. Sandborn","year":"2006","unstructured":"Sandborn WJ, Stenson WF, Brynskov J, et al.: Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study. Clin Gastroenterol Hepatol 2006, 4:203\u2013211.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"53_CR63","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1542-3565(05)00980-8","volume":"4","author":"K. Takeuchi","year":"2006","unstructured":"Takeuchi K, Smale S, Premchand P, et al.: Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006, 4:196\u2013202.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"53_CR64","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/gast.2003.50054","volume":"124","author":"L. Laine","year":"2003","unstructured":"Laine L, Connors LG, Reicin A, et al.: Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology 2003, 124:288\u2013292.","journal-title":"Gastroenterology"},{"key":"53_CR65","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1053\/j.gastro.2008.07.067","volume":"135","author":"L. Laine","year":"2008","unstructured":"Laine L, Curtis SP, Langman M, et al.: Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. Gastroenterology 2008, 135:1517\u20131525.","journal-title":"Gastroenterology"},{"key":"53_CR66","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","volume":"348","author":"J.A. Baron","year":"2003","unstructured":"Baron JA, Cole BF, Sandler RS, et al.: A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003, 348:891\u2013899.","journal-title":"N Engl J Med"},{"key":"53_CR67","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","volume":"348","author":"R.S. Sandler","year":"2003","unstructured":"Sandler RS, Halabi S, Baron JA, et al.: A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003, 348:883\u2013890.","journal-title":"N Engl J Med"},{"key":"53_CR68","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","volume":"342","author":"G. Steinbach","year":"2000","unstructured":"Steinbach G, Lynch PM, Phillips RKS, et al.: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000, 342:1946\u20131952.","journal-title":"N Engl J Med"},{"key":"53_CR69","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0016-5085(03)00887-4","volume":"125","author":"R. Benamouzig","year":"2003","unstructured":"Benamouzig R, Deyra J, Martin A, et al.: Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 2003, 125:328\u2013336.","journal-title":"Gastroenterology"},{"key":"53_CR70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-146-5-200703060-00009","volume":"146","author":"C. Dube","year":"2007","unstructured":"Dube C, Rostom A, Lewin G, et al.: The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the US Preventive Services Task Force. Ann Intern Med 2007, 146:365\u2013375.","journal-title":"Ann Intern Med"},{"key":"53_CR71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.gastro.2007.10.014","volume":"134","author":"R.F. Logan","year":"2008","unstructured":"Logan RF, Grainge MJ, Shepherd VC, et al.: Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008, 134:29\u201338.","journal-title":"Gastroenterology"},{"key":"53_CR72","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","volume":"355","author":"M.M. Bertagnolli","year":"2006","unstructured":"Bertagnolli MM, Eagle CJ, Zauber AG, et al.: Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006, 355:873\u2013884.","journal-title":"N Engl J Med"},{"key":"53_CR73","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1053\/j.gastro.2006.08.079","volume":"131","author":"J.A. Baron","year":"2006","unstructured":"Baron JA, Sandler RS, Bresalier RS, et al.: A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 2006, 131:1674\u20131682.","journal-title":"Gastroenterology"},{"key":"53_CR74","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa061652","volume":"355","author":"N. Arber","year":"2006","unstructured":"Arber N, Eagle CJ, Spicak J, et al.: Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006, 355:885\u2013895.","journal-title":"N Engl J Med"},{"key":"53_CR75","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1158\/1940-6207.CAPR-08-0206","volume":"2","author":"M.M. Bertagnolli","year":"2009","unstructured":"Bertagnolli MM, Eagle CJ, Zauber AG, et al.: Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila Pa) 2009, 2:310\u2013321.","journal-title":"Cancer Prev Res (Phila Pa)"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-009-0053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-009-0053-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-009-0053-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:04:06Z","timestamp":1559433846000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-009-0053-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,20]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1007\/s11894-009-0053-z","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,20]]}}}